article thumbnail

Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions

TechCrunch

Neuroglee Therapeutics , a startup developing digital therapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digital therapeutics for neurodegenerative diseases. Venture investing in elder tech. Neuroglee gets $2.3

article thumbnail

The growing power of digital healthcare: 6 trends to watch in 2022

TechCrunch

GHI Fund President Bill Taranto has spent more than two decades in the healthcare industry and has 15 years of experience in healthcare investing. In addition to his venture investing knowledge, Bill has decades of management operations experience. 4 strategies for building a digital health unicorn. Share on Twitter.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

6 questions investors should ask when evaluating psychedelic biotech companies

TechCrunch

As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. So how do we pick which companies to invest in? Greg Kubin. Contributor.

article thumbnail

JOGO Health Opens Wefunder Campaign to Transform Pain Management

American Entrepreneurship

JOGO is the first-ever digital therapeutics product to use the science of EMG biofeedback to treat neuromuscular diseases. Hourglass Ventures led the investment round that included Mayo Clinic Ventures, the venture arm of the world-renowned hospital.

health 87
article thumbnail

BrainCheck brings in another $10M to detect, manage cognitive impairment

TechCrunch

BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digital therapeutics for Alzheimer’s and related dementias.

article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M in funding. HPA led the round , which will help metaMe continue its preparations for Regulora’s market launch and the build out of metaMe’s commercial infrastructure.

health 113
article thumbnail

Atommerce wants to scale its mental health platform with $16.7M funding

TechCrunch

With the recent funding, Atommerce plans to enhance artificial intelligence and machine learning technology for its platform and invest in digital therapeutics specialized in mental illness. The Series B was led by Hashed, with participation from E&Investment, K2 Investment, and Samsung Next.

health 83